The present invention relates to pharmaceutical composition of thienopyridine derivative for the method of treatment of hepatitis C in humans. The methods of the present invention can be used in patients with hepatitis C administering thienopyrindine derivative preferably prasugrel in combination with one or more anti-hepatits C drugs.